GCM
ANTH
Gruss Capital Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-706,000
| Closed | -$2.56M | – | 52 |
|
|
2016
Q1 | $2.56M | Hold |
706,000
| – | – | 0.08% | 12 |
|
|
2015
Q4 | $3.28M | Hold |
706,000
| – | – | 0.11% | 32 |
|
|
2015
Q3 | $4.3M | Hold |
706,000
| – | – | 0.14% | 29 |
|
|
2015
Q2 | $6.09M | Sell |
706,000
-350,000
| -33% | -$3.02M | 0.22% | 27 |
|
|
2015
Q1 | $4.72M | Buy |
1,056,000
+96,000
| +10% | +$429K | 0.19% | 21 |
|
|
2014
Q4 | $1.52M | Buy |
960,000
+100,000
| +12% | +$158K | 0.04% | 49 |
|
|
2014
Q3 | $1.65M | Buy |
860,000
+833,438
| +3,138% | +$1.6M | 0.07% | 49 |
|
|
2014
Q2 | $90K | Buy |
+26,562
| New | +$90K | ﹤0.01% | 65 |
|